MyoD is a master regulatory gene for myogenesis. Under the control of a retroviral long terminal repeat, MyoD was expressed in a variety of differentiated cell types by using either a DNA transfection vector or a retrovirus. Expression of muscle-specific proteins was observed in chicken, human, and rat primary fibroblasts and in differentiated melanoma, neuroblastoma, liver, and adipocyte lines. The ability of MyoD to activate muscle genes in a variety of differentiated cell lines suggests that no additional tissuespecific factors other than MyoD are needed to activate the downstream program for terminal muscle differentiation or that, if such factors exist, they are themselves activated by MyoD expression.
MyoD is a master regulatory gene for skeletal myogenesis. It is expressed only in skeletal muscle, and, when transfected into a variety of fibroblast or adipoblast cell lines, it converts these cells to muscle (1) (2) (3) (4) . The MyoD protein is a nuclear protein that contains a region of -60 amino acid residues homologous to the c-myc family of proteins (see ref. 5 ). This region is both necessary and sufficient for conversion of C3H/1OT'/2 (1OT'/2) fibroblasts to muscle (3) . MyoD is a DNA-binding protein that binds to the enhancer sequence of the muscle-specific creatine phosphokinase (M-CPK) gene. Preliminary data suggest that it also binds to the enhancers for a number of other muscle-specific genes (6) . The 60-residue myc homology region is both necessary and sufficient for this specific DNA binding (6) . It has also been shown that MyoD activates its own transcription (7) . Autoactivation of MyoD could provide either a positive feedback loop to keep cells committed to myogenesis once MyoD is activated or a mechanism to increase MyoD levels once the gene is activated by upstream factors. Two different genes, myogenin and Myf-5, both with a high degree of homology to MyoD, particularly throughout the myc region, can convert 10T1/2 cells to muscle (8, 9) . The biological relationships between these genes as well as a fourth gene, myd (10) , are presently not clear.
Here we explore the potential of MyoD to activate muscle markers in primary cells and in differentiated tissue culture cell lines. The results demonstrate that a variety of cell types (melanoma, neuroblastoma, liver, and adipocyte) can be induced to express muscle markers by MyoD, which supports the notion that MyoD is a master regulatory locus and also suggests that in these circumstances the activation of the muscle program does not require additional tissue-specific factors other than MyoD. EXPERIMENTAL PROCEDURES Cells. All cells were grown in Dulbecco's modified Eagle's medium (DMEM) with 10% (vol/vol) fetal calf serum. For muscle induction, cells were switched to DMEM with transferrin (10 jg/ml) and insulin (5 jig/ml) for 2 to 3 days. F3 is a myoblast clone derived from 5-azacytidine treatment of 10T1/2 cells (1). BNL liver cells were obtained from the American Type Culture Collection, and myogenic 3T3-L1 adipocytes were made by using the LTR-MyoD expression vector (2) . DNA Clones. LTR-MyoD (2) is a MyoD cDNA in the EMSV-scribe expression vector, which contains a Moloney murine sarcoma virus long terminal repeat (LTR) and a simian virus 40 poly(A) site. pSVAfos contains a deletion of exons II, III, and IV that inactivates the fos gene; pSV-sof contains antisense fos sequences from base pair 175-292. They are described by Schontal et al. (11) . M-CPK-CAT contains 3300 base pairs of upstream M-CPK sequence containing an M-CPK-specific enhancer (12), Des-CAT contains 3400 base pairs of the upstream desmin-controlling region (13) .
Virus Construction and Propagation. An 1156-base-pair Rsa I to Xmn I DNA fragment containing the MyoD coding region was excised from a cDNA clone of MyoD (2) and inserted into the Hpa I site of the murine leukemia virusbased retroviral vector pLXSN (Fig. 1) . DNA clones containing the insert in either the forward (pLMDSN) or reverse (pLDMSN) orientation were isolated. Amphotropic retrovirus-producing cell lines were generated by using PA317 cells as described (14) . Medium harvested after a 12-hr exposure to a confluent layer of cells producing the LMDSN or LDMSN viruses contained about 107 neomycin-resistant colony-forming units per ml when assayed on NIH 3T3 cells.
Abbreviations: M-CPK, muscle-specific creatine phosphokinase; LTR, long terminal repeat; CAT, chloramphenicol acetyltransferase; MHC, myosin heavy chain.
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Virus-containing medium was stored at -70'C. Cells were infected by exposure to virus-containing medium overnight in the presence of Polybrene (4 kug/ml).
General Methods. Myosin heavy chain (MHC) and MyoD immunostaining (3, 16) , Northern analysis (2), chloramphenicol acetyltransferase (CAT) assays (17) , and transfections (3) were performed as described. (2) . We first tested whether MyoD could convert primary "nontransformed" fibroblasts to muscle. A population of dermal fibroblasts from chicken embryos was transfected with an LTR-driven MyoD cDNA expression vector (2) . These cells were converted to elongated, sometimes multinucleated, MHC-positive ( Fig. 2A) , desmin-positive cells (Fig. 2B) at a frequency consistent with that generally obtained with a transient assay (3) . In parallel cultures transfected with a control vector lacking MyoD, small numbers of faintly desmin-positive cells were seen, but none of these stained for MHC and none displayed the elongated, myosin-and desmin-positive phenotype seen in the LTRMyoD transfected cultures.
RESULTS

Conversion
Because the frequency of conversion is low in transient assays and because chicken cells do not yield stable clones, we decided to extend these conclusions by using a MyoDencoding amphotropic retrovirus (LMDSN) Fig. 2D ) fibroblasts were infected with the virus and then transferred to serum-free medium to induce muscle. After 3 days, both types of cells become elongated, and the rat cells begin to fuse and form large multinucleated myotubes (Fig. 2D Upper) . Often up to 50% or more of the rat cell nuclei in these cultures are in myotubes, depending on the multiplicity of infection. In contrast to rat cells, the human cells fused poorly following infection. However, both infected rat and human cells ( Muscle Markers Can Be Activated in Differentiated Cell Lines by MyoD. We previously demonstrated that, besides fibroblasts, three adipocyte lines will convert to muscle when transfected with the MyoD expression vector (2) . Because fibroblasts and muscle can be derived from a common cell (18) and because adipocytes, muscle, and chondrocytes can all be derived from 10T1/2 cells (19) and all of these cells are mesodermal in origin, we decided to ask whether differentiated cell types derived from ectodermal and endodermal germ layers could convert to muscle.
By using either DNA transfection or viral infection, both B16 ( Fig. 3 A and B ) and B78 (data not shown) mouse melanoma cell lines as well as a rat neuroblastoma cell line (B50 clone 5) (Fig. 3D) (20) convert to muscle as assayed by simultaneous staining of individual cells with MHC and desmin antibodies. Both of these cell types are derived from ectoderm. BNL liver cells (derived from endoderm) also activate MHC and desmin (Fig. 3C) . In experiments of others, baby hamster kidney cells can be converted to muscle by transfection with LTR-MyoD (R. Palmiter and S. Hauschka, personal communication), and rat smooth muscle cells can be converted to skeletal muscle by MyoD virus infection (J. Medina and S. Schwartz, personal communication); P19 embryonal carcinoma cells also differentiate into skeletal muscle in the absence of chemical inducers of myogenesis after MyoD transfection (unpublished observations). We conclude that forced expression of MyoD can activate markers indicative of muscle differentiation in cell lines that represent derivatives of each of the three germ layers.
For rat neuroblastoma and for B16 melanoma cells, 10-20% ofthe cell population will activate both MHC and desmin 3 days after retrovirus infection and subsequent induction of the muscle phenotype by growth in low serum. For both of these cell types, expression of MHC and myosin light chain 2 is dependent on serum withdrawal (see Fig. 4B ), indicating that the signaling system for this aspect of muscle induction is not cell type specific.
G418-resistant clones of MyoD-positive, MHC-positive neuroblast or B16 melanoma cells were propagated. Northern analysis of early passage polyclones (Fig. 4 A and B) demonstrates that after induction by serum withdrawal, MHC and myosin light chain 2 genes are expressed. In addition, two cDNA markers, MyoA and MyoH (2), which are induced by MyoD in proliferating myoblasts in the presence of serum, are also expressed in the MyoD-activated neuroblastoma and melanoma cell lines in the presence of serum (Fig. 4 A and D) . Exogenous MyoD also activates endogenous MyoD in some (Fig. 4C, lane 2) , but not all, transfected or infected cell types (7). With MyoD retrovirusinfected melanoma or neuroblastoma cells, activation of the endogenous MyoD could not be detected (Fig. 4C) . With continued passage, these melanoma and neuroblastoma clones lost their ability to produce MyoD as assayed by immunostaining and concommitantly lost their ability to activate muscle markers; however, they remained G418 resistant. We do not know the basis for this effect and, in particular, whether it is a selection for cells that happen to turn off MyoD (MyoD is known to inhibit colony formation in 10T1/2 transfectants; ref.
2) or whether these differentiated cells have an active mechanism for inhibiting MyoD expression. We also do not know whether loss of MyoD is also accompanied by loss of MyoD DNA or RNA or neither. In this regard, we have also transfected and infected MyoD into a number of other cell types (Ca-Co2, colon carcinoma; GH3, rat pituitary; MEL, murine erythroleukemia; and P3881, mouse macrophage), and in each case forced expression of MyoD from the retroviral LTR was not observed.
Expression of Differentiation Markers in Single Cells. In long-term cultures and in (metastable) clones, most B16 melanoma cells remain pigmented, and about half express MHC when induced. At the single cell level, over 90o of MHC-positive cells also contain large numbers of pigment granules (Fig. 5 A and B) . Because the pigment cell markers might be quite stable, this type of assay does not address whether both programs are actively being expressed at the transcriptional level. However, in cultures that are not induced for myogenesis, all cells are pigmented, and by Northern analysis, considerable levels of the MyoD-induced myoblast markers, MyoA and MyoH, are expressed (Fig. 4D) .
After induction of MyoD-activated rat neuroblasts with cAMP (for neuroblast differentiation) and low serum (for muscle differentiation), most cells send out axon-like pro- cesses, and these cells also stain positively for MHC and desmin (Fig. 5C) muscle as assayed by fusion and staining with MHC antibody or fat as assayed by the presence of multiple lipid droplets (data not shown). Individual cells also tended to express either fat or muscle. Thus, expression of fat seems to be incompatible with expression of MHC. Because we have found it impossible to reliably stain fat cell nuclei for MyoD, we cannot be certain that MyoD remains present in the committed adipocytes in the population.
Our conclusion from these studies is that forced expression of MyoD does not turn off the endogenous pigment or neuronal pathway; muscle differentiation does seem to be mutually incompatible with adipogenesis. In heterokaryons between hepatoma cells and myotubes, liver-specific functions are extinguished (21) . Fibroblasts also extinguish liver functions (22, 23) . In heterokaryons between nerve cells and myocytes or between adrenal cells and myocytes, both programs from both fusion partners can coexist (24, 25) , and in early Ascidian embryos, inhibition of cell cleavage results in cells coexpressing markers of several different lineages (26, 27) . In Caenorhabditis elegans, the same experiment results in cells expressing only a single program (28) . As more cell types are studied in this type of analysis, perhaps a clear set of rules will emerge, possibly relating to embryological lineage; for example, perhaps MyoD turns off an endogenous program of differentiation only in lineages closely related to muscle.
Three cell lines tested express MyoD but fail to activate MHC or desmin. These lines are CV1 (an African green monkey kidney-derived line), HeLa (human cervical carcinoma), and HepG2 (human hepatoma). Attempts to activate stable MyoD-expressing CV1 lines by treatment with azacytidine or butyrate or both were not successful. MyoDexpressing CV1 cells grow slowly, elongate, and become multinucleate (properties of MyoD-transfected fibroblasts); however, they did not express any of the tested molecular markers for myogenesis.
Trans-Activation by MyoD. A construction containing the 5' controlling region (3.3 kilobases of upstream sequence) of the M-CPK gene driving CAT expression (12) was used as a target for trans-activation by LTR-driven MyoD. Cotransfection of the two plasmids into 10T1/2 cells followed by muscle cell induction in serum-free medium resulted in high levels of CAT expression (Fig. 6A) . M-CPK-CAT alone or with a control vector DNA gave no detectable activity. Coexpression of MyoD also activated a desmin-CAT construction (13) (Fig. 6A) . SV2-CAT was also activated, but only 2-or 3-fold (data not shown). Activation ofthe enhancerless SV1-CAT plasmid could not be detected (data not shown). These results show that in the context of transfected 10T/2 cells, MyoD can trans-activate, either directly or indirectly, expression from the M-CPK-or desmin-controlling region.
To test whether other cell types were also permissive for MyoD trans-activation, these same protocols were used to transfect B16 melanoma cells and rat neuroblastoma cells. In both cases, activation by MyoD was observed (Fig. 6B) . These results suggest that if additional regulatory components are needed for this activity, these cells as well as 10T1/2 cells seem to express them.
In contrast, trans-activation of M-CPK-CAT by cotransfection with MyoD was not observed in HeLa or CV1 cells (Fig. 6C) , cells that do not convert readily to muscle after forced expression of MyoD. Thus, cell types that can be converted to muscle trans-activate M-CPK-CAT with MyoD, and cells that do not convert to muscle do not trans-activate M-CPK-CAT with MyoD.
The failure of HeLa and CV1 to support MyoD-mediated activation by these two assays could reflect an absence of an essential positive factor or the presence of a negative factor. The putative negative factor could act in cis at sites in the M-CPK-controlling region or in trans, either directly on the MyoD protein or with an element that interacts with MyoD. MyoD itself. Thus, in terms of cell type-specific gene expression, we view the expression of MyoD as a nodal point along the pathway to muscle cell differentiation. We postulate that the endogenous MyoD gene could be activated by specific combinations of inductive, spatial, temporal, and lineage cues that would define the time and position in the embryo (i.e., in the somites) where muscle cells should be determined. Once this temporal and positional information is established, master genes (like MyoD) would be activated to encode cell type. Confirmation of this view will require a detailed analysis of the regulation of the endogenous MyoD gene in combination with an analysis of the trans-acting elements responsible for the initial activation ofMyoD during development.
